New strategies for the treatment and prevention of primary headache disorders
- 27 October 2016
- journal article
- review article
- Published by Springer Nature in Nature Reviews Neurology
- Vol. 12 (11) , 635-650
Abstract
The primary headache disorders, which include migraine, cluster headache and tension-type headache, are among the most common diseases and leading causes of disability worldwide. The available treatment options for primary headache disorders have unsatisfactory rates of efficacy, tolerability and patient adherence. In this Review, we discuss promising new approaches for the prevention of primary headache disorders, such as monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor, and small-molecule CGRP receptor antagonists. Neuromodulation approaches employing noninvasive or implantable devices also show promise for treating primary headache disorders. Noninvasive treatments, such as transcranial magnetic stimulation and transcutaneous peripheral nerve stimulation, are delivered by devices that patients can self-administer. Implantable devices targeting the occipital nerves, sphenopalatine ganglion or high cervical spinal cord are placed using percutaneous and/or surgical procedures, and are powered either wirelessly or by surgically implanted batteries. These new and emerging treatments have the potential to address unmet patient needs and reduce headache-associated disability.Keywords
This publication has 110 references indexed in Scilit:
- Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?The Journal of Headache and Pain, 2013
- Assessing acute systemic effects of an inhaled drug with serial echocardiography: a placebo-controlled comparison of inhaled and intravenous dihydroergotamineDrug Design, Development and Therapy, 2013
- Transcranial Direct Current Stimulation (tDCS) of the visual cortex: a proof-of-concept study based on interictal electrophysiological abnormalities in migraineThe Journal of Headache and Pain, 2013
- Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: A randomized, sham-controlled studyCephalalgia, 2013
- Migraine: the seventh disablerThe Journal of Headache and Pain, 2013
- Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraineNeuropsychiatric Disease and Treatment, 2012
- MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late TreatmentsMayo Clinic Proceedings, 2011
- Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility studyCephalalgia, 2010
- Randomized, controlled trial of telcagepant for the acute treatment of migraineNeurology, 2009
- Prevalence of cluster headache in Germany: results of the epidemiological DMKG studyJournal of Neurology, Neurosurgery & Psychiatry, 2007